US Patent 11400045 Treatment with powdered intranasal epinephrine
All edits
Edits on 17 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 22 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
114000450
Date of Patent
August 2, 2022
0Patent Application Number
171355280
Date Filed
December 28, 2020
0Patent Primary Examiner
Edits on 22 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
114000450
Date of Patent
August 2, 2022
0Patent Application Number
171355280
Date Filed
December 28, 2020
0Patent Primary Examiner
Edits on 3 Aug, 2022
Golden AI
Edits made to:
Infobox (+12 properties)
Article (+358 characters)
US Patent 11400045 Treatment with powdered intranasal epinephrine
Article
Disclosed is a pharmaceutical composition in dry powder form for intranasal administration, having an anti-anaphylactic adrenergic receptor agonist in the form of dry powder for intranasal administration, the composition having solid particles of the active agent in combination with at least one functional additive, and solid particles of an inert carrier.
Infobox
Is a
Patent jurisdiction
Patent number
11400045
Date of patent
August 2, 2022
Patent application number
17135528
Date Filed
December 28, 2020
Patent primary examiner
Find more entities like US Patent 11400045 Treatment with powdered intranasal epinephrine
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.